International Biotechnology Trust plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IBT.L research report →
Companywww.internationalbiotrust.com
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
- CEO
- Catherine Elizabeth Bingham
- IPO
- 1994
- HQ
- London, GB
Price Chart
Valuation
- Market Cap
- $313.82M
- P/E
- 4.13
- P/S
- 3.34
- P/B
- 1.01
- EV/EBITDA
- 4.45
- Div Yield
- 3.23%
Profitability
- Gross Margin
- 81.42%
- Op Margin
- 80.59%
- Net Margin
- 82.27%
- ROE
- 27.35%
- ROIC
- 21.78%
Growth & Income
- Revenue
- $18.69M · -55.86%
- Net Income
- $-1,170,000 · -103.01%
- EPS
- $-0.03 · -103.23%
- Op Income
- $-21,000
- FCF YoY
- -100.00%
Performance & Tape
- 52W High
- $1020.26
- 52W Low
- $550.00
- 50D MA
- $942.34
- 200D MA
- $886.68
- Beta
- 0.52
- Avg Volume
- 48.47K
Get TickerSpark's AI analysis on IBT.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IBT.L Coverage
We haven't published any research on IBT.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IBT.L Report →